Rosseneu M, Vinaimont N, Musliner T A, Bernier D, Herbert P N, Belpaire F
Clin Chem. 1984 Feb;30(2):234-7.
A quantitative assay based on endpoint immunonephelometry was developed for human apolipoprotein A-II (apoA-II) in plasma or serum. Dilution of plasma samples with a 0.1 mol/L solution of sodium cholate enhanced the quantification. We used either purified apoA-II as the primary standard or plasma as a secondary standard. Results correlated well (r = 0.90) with those by a double-antibody radioimmunoassay for 63 serum samples from both normal and hyperlipemic individuals. The interassay coefficient of variation for the immunonephelometric assay was 7% within a working range between 0.05 and 0.7 microgram of apoA-II per sample (corresponding to a 1500-fold final dilution of serum). No extraction of samples with organic solvent is necessary if the triglyceride concentration is less than 4 g/L.
建立了一种基于终点免疫比浊法的血浆或血清中人类载脂蛋白A-II(apoA-II)定量检测方法。用0.1mol/L胆酸钠溶液稀释血浆样本可提高定量准确性。我们既使用纯化的apoA-II作为一级标准品,也使用血浆作为二级标准品。对来自正常人和高脂血症患者的63份血清样本进行检测,结果与双抗体放射免疫法的结果相关性良好(r = 0.90)。在每个样本中apoA-II含量为0.05至0.7微克的工作范围内(相当于血清最终稀释1500倍),免疫比浊法的批间变异系数为7%。如果甘油三酯浓度低于4g/L,则无需用有机溶剂萃取样本。